Veradermics (MANE)
Develops extended-release oral minoxidil for male and female pattern hair loss.
$99.29
Pre-market+0.84 (+0.85%)
At close$98.45(+0.96%)
Something off on this page? Send us feedback.
Next report
Nov 10, 2026
estimated · in 68 days
EPS estimate
−$0.59
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
————Mar '26May '26Aug '26Nov '26
Reported————−$0.76−$1.32−$0.58Pending
Estimate————−$1.81−$0.56−$0.65−$0.59
Surprise————+58.1%−135.7%+10.4%—
RevenueReportedEstimate
————Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.59 | — | — |
| Aug 2026 | −$0.65 | −$0.58 | +10.4% |
| Jun 2026 | −$0.64 | — | — |
| May 2026 | −$0.56 | −$1.32 | −135.7% |
| Mar 2026 | −$1.81 | −$0.76 | +58.1% |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | −$0.59 | — | — | — | — | — | — |
| Aug 11, 2026 | −$0.65 | −$0.58 | +10.4% | — | — | — | −1.6% |
| Jun 3, 2026 | −$0.64 | — | — | — | — | — | — |
| May 12, 2026 | −$0.56 | −$1.32 | −135.7% | — | — | — | +3.1% |
| Mar 30, 2026 | −$1.81 | −$0.76 | +58.1% | — | — | — | +3.8% |